Levi A Garraway

发表

Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience

Yaping Yang, Katrina A B Goddard, Kathryn M Porter, 2018, Molecular genetics & genomic medicine.

Inferring Loss-of-Heterozygosity from Unpaired Tumors Using High-Density Oligonucleotide SNP Arrays

Wing Hung Wong, Rameen Beroukhim, Levi A Garraway, 2006, PLoS Comput. Biol..

Abstract PR03: Genetic mechanisms of immune evasion in colorectal cancer

Benjamin J. Raphael, Matteo Pellegrini, Ming Yu, 2018, Systems Immuno-Oncology.

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.

Yiling Lu, Gordon B Mills, Bhaskar Dutta, 2009, Cancer cell.

RNF43 is frequently mutated in colorectal and endometrial cancers

Kristian Cibulskis, Joseph Rosenbluh, Gad Getz, 2014, Nature Genetics.

Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations.

Nikhil Wagle, Gad Getz, Mari Mino-Kenudson, 2015, Cancer discovery.

Precision oncology: an overview.

Levi A Garraway, L. Garraway, J. Verweij, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens

Pablo Tamayo, Aviad Tsherniak, Rameen Beroukhim, 2013, Genome research.

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling.

Nikhil Wagle, Levi A Garraway, William C Hahn, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Epigenomic alterations in localized and advanced prostate cancer.

Kyung Park, Levi A Garraway, Eugenia G. Giannopoulou, 2013, Neoplasia.

Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.

Levi A Garraway, Kwok-Kin Wong, Neal Rosen, 2012, Cancer discovery.

Assigning clinical meaning to somatic and germ-line whole-exome sequencing data in a prospective cancer precision medicine study

Carrie Cibulskis, Nikhil Wagle, Steven Joffe, 2017, Genetics in Medicine.

Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly dividing de‐differentiated state

Levi A Garraway, Mohammad Fallahi-Sichani, Jia-Ren Lin, 2017, Molecular systems biology.

Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.

Levi A Garraway, Lynda Chin, Kwok-Kin Wong, 2007, Cancer research.

Genomic Analysis of Head and Neck Squamous Cell Carcinoma Cell Lines and Human Tumors: A Rational Approach to Preclinical Model Selection

Levi A Garraway, Vivian Wai Yan Lui, Hua Li, 2014, Molecular Cancer Research.

Inherited DNA Repair Defects in Colorectal Cancer

Nathanael D. Moore, Li Liu, Reiko Nishihara, 2018, bioRxiv.

High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.

Nikhil Wagle, Levi A Garraway, William C Hahn, 2012, Cancer discovery.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Zhi Wei, Hongye Liu, Wei Huang, 2018, Cancer discovery.

MAPK Pathway Suppression Unmasks Latent DNA Repair Defects and Confers a Chemical Synthetic Vulnerability in BRAF-, NRAS-, and NF1-Mutant Melanomas.

Levi A Garraway, Keith T Flaherty, Thomas De Raedt, 2019, Cancer discovery.

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer

Matteo Benelli, Clarisse Marotz, Davide Prandi, 2016, Nature Medicine.

Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.

Laura Tolosi, Michael Peyton, Thomas Zander, 2009, The Journal of clinical investigation.

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

Mingyang Song, Yin Cao, Reiko Nishihara, 2015, Gut.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Nikhil Wagle, Peter Tarczy-Hornoch, Richard M Myers, 2016, American journal of human genetics.

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board

Nikhil Wagle, Steven Joffe, Levi A Garraway, 2016, Personalized medicine.

Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

Thomas LaFramboise, Levi A Garraway, Kwok-Kin Wong, 2006, Nature Medicine.

Institutional implementation of clinical tumor profiling on an unselected cancer population.

Marian Harris, Ethan Cerami, Frank C Kuo, 2016, JCI insight.

Unraveling the clonal hierarchy of somatic genomic aberrations

Alessandro Romanel, Davide Prandi, Levi A Garraway, 2014, Genome Biology.

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Adam Kiezun, Chandra Sekhar Pedamallu, Nikhil Wagle, 2014, Proceedings of the National Academy of Sciences.

Genomics-driven oncology: framework for an emerging paradigm.

Levi A Garraway, L. Garraway, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterizing genomic alterations in cancer by complementary functional associations

Gabriela Alexe, Chiara Romualdi, Pablo Tamayo, 2016, Nature Biotechnology.

Circumventing cancer drug resistance in the era of personalized medicine.

Levi A Garraway, L. Garraway, P. Jänne, 2012, Cancer discovery.

High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells.

Joel Greshock, Levi A Garraway, Fred Harbinski, 2016, Cancer research.

A Convergence-Based Framework for Cancer Drug Resistance.

Levi A Garraway, L. Garraway, C. Johannessen, 2018, Cancer cell.

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

Kristian Cibulskis, Gad Getz, Shuji Ogino, 2011, Nature Genetics.